![Matthias Staehelin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthias Staehelin has worked as an Independent Director at Nuclidium AG and as a Trustee & Secretary at JFG Life Sciences Stiftung der Universität Basel.
| Companies | Position | Start |
|---|---|---|
JFG Life Sciences Stiftung der Universität Basel
 JFG Life Sciences Stiftung der Universität Basel Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Director/Board Member | - |
Nuclidium AG
 Nuclidium AG Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops radiopharmaceuticals for treatment of cancer | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 2 |
|---|---|
JFG Life Sciences Stiftung der Universität Basel
JFG Life Sciences Stiftung der Universität Basel Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Nuclidium AG
Nuclidium AG Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops radiopharmaceuticals for treatment of cancer | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
